IGF2BP1, IGF2BP2 and IGF2BP3 are dysregulated in many tumor types (84), being associated with chemoresistance in glioblastoma (132), ovarian (133) and colorectal (134) cancer. This evidence concerns the gene IGF2BP3 and glioblastoma.